New Study Expands Range of Potential Alzheimer’s Drugs
Treatments may not need to cross the blood-brain barrier to affect brain insulin resistance
Alzheimer's Disease
New Study Finds Link Between COVID-19 Mortality and Gene Associated with Alzheimer's
In a study of 300 mice with variants of APOE gene, those with the 2 and 4 alleles are at higher risk of negative COVID outcomes
New Era in Alzheimer’s Drug Development Based on Biology of Aging
Editorial underscores need for combination therapy to treat and prevent Alzheimer’s disease
Optical Fiber Imaging Method Advances Studies of Alzheimer's Disease
Technique exploits light scrambling to improve deep-tissue fluorescence imaging
New Drug Screening Method Answers Why Alzheimer’s Drugs Fail
Method looks at what disease mechanisms, or endotypes, change in patients’ neurons as a result of treatment
Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G β-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
When cleared, Fujirebio’s FDA-designated breakthrough device is expected to be among the first commercially available in vitro diagnostics for patients being evaluated for Alzheimer’s disease in the US
Could Foods Such as Cheese and Wine Reduce Cognitive Decline?
Recent study is a first-of-its-kind large scale analysis that connects specific foods to later-in-life cognitive acuity
Space Station Provides Ideal Environment to Study Alzheimer's
Gravity affects protein assembly related to Alzheimer's disease
Nanodevices Could Thwart Formation of Alzheimer's Plaques
Researchers are studying ways to prevent β-amyloid peptides from forming these dangerous plaques in order to halt development of Alzheimer's disease in the brain
Scientists Discover Gene That Increases Risk of Alzheimer's
Researchers found two mutations in the gene endothelin-converting enzyme 2 (ECE2) which impaired its ability to break down amyloid beta protein